Searching for the mechanism(s) of ECT's therapeutic effect

Journal of ECT

Volumn 30, Issue 2, 2014, Pages 87-89

  McCall, W Vaughn ^a   Andrade, Chittaranjan ^b   Sienaert, Pascal ^c  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

^c University Psychiatric Center St Norbertushuis   (Belgium)

Author keywords

ECT; Mechanism

Indexed keywords

ANTIDEPRESSANT AGENT; GLUCOCORTICOID; LIPID; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR;

AMNESIA; AMYGDALOID NUCLEUS; ANTICONVULSANT ACTIVITY; ANTIDEPRESSANT ACTIVITY; ANTIMANIC EFFECT; ANTIPARKINSONIAN EFFECT; ANTIPSYCHOTIC EFFECT; AUTOPSY; BIOLOGICAL ACTIVITY; BIPOLAR DISORDER; BRAIN DAMAGE; BRAIN DEPTH STIMULATION; BRAIN HYPOXIA; BRAIN LEVEL; BRAIN REGION; CEREBELLUM; CONTROLLED CLINICAL TRIAL (TOPIC); DEPRESSION; DRUG MECHANISM; DYSTHYMIA; ELECTRIC SHOCK; ELECTROCONVULSIVE THERAPY; ELECTROENCEPHALOGRAM; ELECTROENCEPHALOGRAPHY; HIPPOCAMPUS; HUMAN; LIBIDO; MENTAL DISEASE; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; NEUROIMAGING; NONHUMAN; PLACEBO EFFECT; PSYCHOANALYTIC THEORY; PSYCHOLOGICAL THEORY; REASSURANCE; REM SLEEP; REVIEW; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; SLEEP STAGE; SYNAPSE; THERAPY EFFECT; VAGUS NERVE STIMULATION; ANIMAL; MENTAL DISORDERS; PROCEDURES;

ANIMALS; ELECTROCONVULSIVE THERAPY; HUMANS; MENTAL DISORDERS;

EID: 84901638755     PISSN: 10950680     EISSN: 15334112     Source Type: Journal    
DOI: 10.1097/YCT.0000000000000121     Document Type: Review

References (45)

1. Dunne RA, McLoughlin DM. Systematic review and meta-analysis of bifrontal electroconvulsive therapy versus bilateral and unilateral electroconvulsive therapy in depression. World J Biol Psychiatry. 2012;13: 248-248.
2. Kellner CH, Knapp R, Husain MM, et al. Bifrontal, bitemporal and right unilateral electrode placement in ECT: randomised trial. Br J Psychiatry. 2010;196:226-234.
3. Spaans HP, Kho KH, Verwijk E, et al. Efficacy of ultrabrief pulse electroconvulsive therapy for depression: A systematic review. J Affect Disord. 2013;150:720-726.
4. McCall WV, Reboussin D, Prudic J, et al. Poor health-related quality of life prior to ECT in depressed patients normalizes with sustained remission after ECT. J Affect Disord. 2013;147:107-111.
5. ChanpattanaW, Chakrabhand ML, Kongsakon R, et al. Short-term effect of combined ECT and neuroleptic therapy in treatment-resistant schizophrenia. J ECT. 1999;15:129-139. (Pubitemid 30012229)
6. Sackeim HA, Dillingham EM, Prudic J, et al. Effect of concomitant pharmacotherapy on electroconvulsive therapy outcomes: short-term efficacy and adverse effects. Arch Gen Psychiatry. 2009;66:729-737.
7. Pompili M, Lester D, Dominici G, et al. Indications for electroconvulsive treatment in schizophrenia: A systematic review. Schizophr Res. 2013;146:1-9.
8. van Schaik A, Comijs H, Sonnenberrg C, et al. Efficacy and safety of continuation and maintenance ECT in depressed elderly: A systematic review. Am J Geriatr Psychiatry. 2012;20:5-17.
9. Read J, Bentall R. The effectiveness of electroconvulsive therapy: A literature review. Epidemiol Psichiatr Soc. 2010;19:333-347.
10. Fosse R, Read J. Electroconvulsive treatment: hypotheses about mechanisms of action. Frontiers in Psychiatry. 2013;4:94.
11. Blease CR. Electroconvulsive therapy, the placebo effect and informed consent. Journal of Medical Ethics. 2013;39:166-170.
12. Devanand DP, Dwork AJ, Hutchinson ER, et al. Does ECT alter brain structure? Am J Psychiatry. 1994;151:957-970. (Pubitemid 24208629)
13. Scalia J, Lisanby SH, Dwork AJ, et al. Neuropathologic examination after 91 ECT treatments in a 92-year-old woman with late-onset depression. J ECT. 2007;23:96-98. (Pubitemid 46869760)
14. Lippman S, Manshadi M, Wehry M, et al. 1,250 electroconvulsive treatments without evidence of brain injury. Br J Psychiatry. 1985;147:203-204. (Pubitemid 15233285)
15. McCall WV. Electroconvulsive therapy and placebo effects: does full disclosure affect expectancy and satisfaction? J ECT. 2006; 22:161-162. (Pubitemid 44379368)
16. Andrade C. There's more to placebo-related improvement than the placebo effect alone. J Clin Psychiatry. 2012; 73:1322-1325.
17. Hrobjartsson A, Gotzsche PC. Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment. N Engl J Med. 2001;344:1594-1602. (Pubitemid 32479913)
18. Masoudzadeh A, Khalilian AR. Comparative study of clozapine, electroshock and the combination of ECT with clozapine in treatment-resistant schizophrenic patients. Pak J Biol Sci. 2007; 10:4287-4290. (Pubitemid 350158596)
19. Fink M. Convuls Ther. New York, NY: Raven Press Books, Ltd; 1979.
20. Sackeim HA, Prudic J, Devanand DP, et al. Effects of stimulus intensity and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. N Engl J Med. 1993;328: 839-846. (Pubitemid 23084338)
21. Sienaert P, Vansteelandt K, Demyttenaere K, et al. Randomized comparison of ultra-brief bifrontal and unilateral electroconvulsive therapy for major depression: cognitive side-effects. J Affect Disord. 2010;122:60-67.
22. Rosenquist PB, Miller B, Pillai A. The antipsychotic effects of ECT: A review of possible mechanisms. J ECT. 2014;30:125-131.
23. Medda P. The mood-stabilizing effects of ECT. J ECT. In Press.
24. Dhossche D. Vagal intimations for catatonia and electroconvulsive therapy. J ECT. 2014; 30: 111-115.
25. Lanzenberger R. Neurotransmitters and ECT. J ECT. 2014;30:116-121.
26. Haskett R. Electroconvulsive therapy's mechanism of action: neuroendocrine hypotheses. J ECT. 2014;30:107-110.
27. Bouckaert F, Sienaert P, Obbels J, et al. ECT: its brain enabling effects. A review of electroconvulsive therapy-induced structural brain plasticity. J ECT. 2014;30:143-151.
28. Kellner CH. Electroconvulsive therapy (ECT) in Parkinson's disease: ECS and dopamine enhancement. J ECT. 2014;30:122-124.
29. Kluge M, Schussler P, Steiger A. Duloxetine increases stage 3 sleep and suppresses rapid eye movement (REM) sleep in patients with major depression. Eur Neuropsychopharmacol. 2007;17:527-531. (Pubitemid 46755559)
30. Coffey CE, McCall WV, Hoelscher TJ, et al. Effects of ECT on polysomnographic sleep: A prospective investigation. Convuls Ther. 1988;4:269-279. (Pubitemid 19010797)
31. Lahmeyer HW, Janicak P, Easton M, et al. ECT's effect on sleep in major depression. Sleep Res. 1989;18:346.
32. Steiger A, Kimura M. Wake and sleep EEG provide biomarkers in depression. J Psychiatr Res. 2010;44:242-252.
33. Linkowski P, Mendlewicz J, Kerkhofs M, et al. 24-hour profiles of adrenocorticotropin, cortisol, and growth hormone in major depressive illness: effect of antidepressant treatment. J Clin Endocrinol Metab. 1987;65:141-152. (Pubitemid 17092102)
34. Pittenger C, Duman RS. Stress, depression, and neuroplasticity: A convergence of mechanisms. Neuropsychopharmacology. 2008; 33:88-109. (Pubitemid 350191319)
35. Andrade C, Rao NS. How antidepressant drugs act: A primer on neuroplasticity as the eventual mediator of antidepressant efficacy. Indian J Psychiatry. 2010;52:378-386.
36. Chen F, Madsen TM, Wegener G, et al. Repeated electroconvulsive seizures increase the total number of synapses in adult male rat hippocampus. Eur Neuropsychopharmacol. 2009; 19:329-338.
37. Smitha JSM, Roopa R, Khaleel N, et al. Images in ECT: ECS dose-dependently increases dendritic arborization in the CA1 region of the rat hippocampus. J ECT. 2013;29:156-157.
38. Smitha JSM, Roopa R, Sagar BKC, et al. Images in ECT: ECS dose-dependently increases cell proliferation in the subgranular region of the rat hippocampus. J ECT. In Press.
39. Khaleel N, Roopa R, Sagar BKC, et al. Images in electroconvulsive therapy: pilot impressions suggesting that ECT reduces excitatory synapses in the basolateral amygdala. Indian J Psychiatry. 2013; 55: 204-205.
40. Khaleel N, Roopa R, Smitha JSM, et al. Images in electroconvulsive therapy: ECT attenuates dendritic arborisation in the basolateral amygdala. J ECT. 2013;29:156-157.
41. Nagaraja N, Andrade C, Sudha S, et al. Glucocorticoid mechanisms may contribute to ECT-induced retrograde amnesia. Psychopharmacology (Berl). 2007;190:73-80. (Pubitemid 44885345)
42. Andrade C, Singh NM, Thyagarajan S, et al. Possible glutamatergic and lipid signalling mechanisms in ECT-induced retrograde amnesia: experimental evidence for involvement of COX-2, and review of literature. J Psychiatr Res. 2008;42:837-850. (Pubitemid 351787734)
43. Andrade C, Thyagarajan S, Singh NM, et al. Celecoxib as an in vivo probe of cyclooxygenase-2 mechanisms underlying retrograde amnesia in an animal model of ECT. J Neural Transm. 2008; 115:1063-1070.
44. Andrade C, Shaikh SA, Narayan L, et al. Administration of a selective glucocorticoid antagonist attenuates electroconvulsive shock-induced retrograde amnesia. J Neural Transm. 2012;119:337-344.
45. McCall WV. Psychiatry and psychology in the writings of L. Ron Hubbard. J Relig Health. 2007;46:437-447.